CHATTANOOGA, Tenn. – On Wednesday,Parkridge Medical Centeradvanced its commitment to high-tech heart care by implanting a patient with the city’s first Boston Scientific INCEPTA™ Cardiac Resynchronization Therapy Defibrillator (CRT-D) device for advanced heart failure management.
The Incepta device works to regulate a person’s heartbeat and provides top of the line wireless technology with state of the art arrhythmia detection. It pairs with the Latitude heart failure management system, which includes a special scale and blood pressure cuff that automatically send patient data to the physician’s office when measurements are taken. This may increase the benefits for patients and physicians as it can minimize the number of in-person office visits that a patient must make after undergoing a cardiac procedure.
“The Incepta CRT-D device is an advanced therapeutic tool whose functionality can be adjusted to match specific patient needs,” said interventional cardiologist Timothy Talbert, who performed the first Incepta implantation procedure at Parkridge. “It is designed to be easier for physicians to implant. It also has many benefits for patients - this is a premium high-energy CRT-D device that is the world’s smallest and thinnest. It offers advanced battery technology with excellent longevity.”
CRT-Ds have been proven in clinical studies to save and extend lives by preventing sudden cardiac death (SCD) and treating heart failure. Each year, SCD claims the lives of up to 460,000 people in the U.S. alone, and more people die from SCD than from lung cancer, breast cancer and AIDS combined.
“This technology is expected to help hospitals lower readmission rates for heart failure patients by helping physicians to catch troublesome changes in a patient’s weight or blood pressure before they become serious enough to require rehospitalization,” notes Parkridge Heart Center director Barry Bell.
Nearly 22 million people worldwide currently suffer from heart failure, a debilitating condition in which the heart weakens and gradually loses the ability to pump blood effectively. Approximately one million new cases of heart failure are diagnosed annually worldwide, making it the most rapidly growing cardiovascular disorder.
About Parkridge Medical Center
Parkridge Medical Center has been providing advanced medical and surgical services with compassionate care to patients in the Chattanooga and north Georgia area since 1971. The Parkridge advantage is a focus on service, individualized care and convenience for patients. The Sarah Cannon Cancer Center, an American College of Surgeons approved and commended oncology program, offers the latest in cancer diagnosis and treatment. Parkridge is an accredited chest pain center providing 24-hour emergency care and intensive care, as well as Acute Rehabilitation, surgical services, vascular care, orthopaedics, a sleep disorders center, and comprehensive cardiac care including diagnostic, surgical and rehabilitation services. Parkridge was the first hospital in the region to perform robotic surgery and remains the most experienced team, having performed over 1500 robotic surgeries. Parkridge Medical Center, Parkridge East and Parkridge Valley are all part of the Parkridge Health System. For more information, please visit www.ParkridgeMedicalCenter.com or call MedLine at (800) 242-5662.
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.